Opportunities and methods for studying alternative splicing in cancer with RNA-Seq

Cancer Lett. 2013 Nov 1;340(2):179-91. doi: 10.1016/j.canlet.2012.11.010. Epub 2012 Nov 27.

Abstract

The biogenesis, development and metastases of cancer are associated with many variations in the transcriptome. Alternative splicing of genes is a major post-transcriptional regulation mechanism that is involved in many types of cancer. The next-generation sequencing applied on RNAs (RNA-Seq) provides a new technology for studying transcriptomes. It provides an unprecedented opportunity for quantitatively studying alternative splicing in a systematic way. This mini-review summarizes the current RNA-Seq studies on cancer transcriptomes especially studies on cancer-related alternative splicing, and discusses the strategy for quantitative study of alternative splicing in cancers with RNA-Seq, the bioinformatics methods available and existing questions.

Keywords: Alternative splicing; Bioinformatics; Cancer; RNA-Seq; Transcriptomes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alternative Splicing*
  • Animals
  • Biomarkers, Tumor / genetics*
  • Computational Biology
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Genome, Human*
  • Genomics / methods*
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Neoplasms / diagnosis
  • Neoplasms / genetics*
  • Neoplasms / therapy
  • Phenotype
  • Precision Medicine
  • Predictive Value of Tests
  • Prognosis
  • RNA, Neoplasm / metabolism*
  • Sequence Analysis, RNA*

Substances

  • Biomarkers, Tumor
  • RNA, Neoplasm